F.D.A. Approves Sickle Cell Treatments, Including One That Uses CRISPR
People with the genetic disease have new opportunities to eliminate their symptoms, but the treatments come with obstacles that limit its reach.
Why We’re Stuck in a Constant Cycle of Drug Shortages
A few simple solutions could save lives and ease the struggles of countless Americans.
Years After Monsanto Deal, Bayer’s Roundup Bills Keep Piling Up
Juries recently awarded plaintiffs more than $2 billion in damages tied to Roundup, the weedkiller that has been linked to cancer. Bayer is fighting back.
CVS Says It Will Change the Way Its Pharmacies Are Paid
The drugstore chain is introducing a model that will compensate pharmacies based on how much they paid for a drug, as well as a set markup and service fee.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.